BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32949309)

  • 1. Identification of novel fusion transcripts in meningioma.
    Khan AB; Gadot R; Shetty A; Bayley JC; Hadley CC; Cardenas MF; Jalali A; Harmanci AS; Harmanci AO; Wheeler DA; Klisch TJ; Patel AJ
    J Neurooncol; 2020 Sep; 149(2):219-230. PubMed ID: 32949309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas.
    Schieffer KM; Agarwal V; LaHaye S; Miller KE; Koboldt DC; Lichtenberg T; Leraas K; Brennan P; Kelly BJ; Crist E; Rusin J; Finlay JL; Osorio DS; Sribnick EA; Leonard JR; Feldman A; Orr BA; Serrano J; Vasudevaraja V; Snuderl M; White P; Magrini V; Wilson RK; Mardis ER; Boué DR; Cottrell CE
    Am J Surg Pathol; 2021 Mar; 45(3):329-340. PubMed ID: 33074854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.
    Zhang X; Jia H; Lu Y; Dong C; Hou J; Wang Z; Wang F; Zhong H; Wang L; Wang K
    Discov Med; 2014 Dec; 18(101):301-311. PubMed ID: 25549701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma.
    Paramasivam N; Hübschmann D; Toprak UH; Ishaque N; Neidert M; Schrimpf D; Stichel D; Reuss D; Sievers P; Reinhardt A; Wefers AK; Jones DTW; Gu Z; Werner J; Uhrig S; Wirsching HG; Schick M; Bewerunge-Hudler M; Beck K; Brehmer S; Urbschat S; Seiz-Rosenhagen M; Hänggi D; Herold-Mende C; Ketter R; Eils R; Ram Z; Pfister SM; Wick W; Weller M; Grossmann R; von Deimling A; Schlesner M; Sahm F
    Acta Neuropathol; 2019 Aug; 138(2):295-308. PubMed ID: 31069492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.
    Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
    J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analysis of synchronous intracranial meningiomas with different histological grades.
    Chowdhury T; Yoo Y; Seo Y; Dho YS; Kim S; Choi A; Choi M; Park SH; Park CK; Lee SH; Lee JY
    J Neurooncol; 2018 May; 138(1):41-48. PubMed ID: 29423538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design.
    Everson RG; Hashimoto Y; Freeman JL; Hodges TR; Huse J; Zhou S; Xiu J; Spetzler D; Sanai N; Kim L; Kesari S; Brenner A; De Monte F; Heimberger A; Raza SM
    J Neurooncol; 2018 Sep; 139(2):469-478. PubMed ID: 29846894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inversion-mediated gene fusions involving NAB2-STAT6 in an unusual malignant meningioma.
    Gao F; Ling C; Shi L; Commins D; Zada G; Mack WJ; Wang K
    Br J Cancer; 2013 Aug; 109(4):1051-5. PubMed ID: 23860521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor nodules.
    Torres-Martín M; Kusak ME; Isla A; Burbano RR; Pinto GR; Melendez B; Castresana JS; Rey JA
    Cancer Genet; 2015 Jun; 208(6):327-32. PubMed ID: 25981829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system.
    Yuzawa S; Nishihara H; Yamaguchi S; Mohri H; Wang L; Kimura T; Tsuda M; Tanino M; Kobayashi H; Terasaka S; Houkin K; Sato N; Tanaka S
    Mod Pathol; 2016 Jul; 29(7):708-16. PubMed ID: 27102344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profile of human meningioma cell lines.
    Mei Y; Bi WL; Greenwald NF; Agar NY; Beroukhim R; Dunn GP; Dunn IF
    PLoS One; 2017; 12(5):e0178322. PubMed ID: 28552950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonality of multiple meningiomas.
    Stangl AP; Wellenreuther R; Lenartz D; Kraus JA; Menon AG; Schramm J; Wiestler OD; von Deimling A
    J Neurosurg; 1997 May; 86(5):853-8. PubMed ID: 9126902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5.
    Abedalthagafi MS; Merrill PH; Bi WL; Jones RT; Listewnik ML; Ramkissoon SH; Thorner AR; Dunn IF; Beroukhim R; Alexander BM; Brastianos PK; Francis JM; Folkerth RD; Ligon KL; Van Hummelen P; Ligon AH; Santagata S
    Oncotarget; 2014 Nov; 5(21):10596-606. PubMed ID: 25347344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas.
    Vasan V; Dullea JT; Devarajan A; Ali M; Rutland JW; Gill CM; Kinoshita Y; McBride RB; Gliedman P; Bederson J; Donovan M; Sebra R; Umphlett M; Shrivastava RK
    J Neurooncol; 2023 Jan; 161(2):309-316. PubMed ID: 36436149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas.
    Boetto J; Bielle F; Sanson M; Peyre M; Kalamarides M
    Neuro Oncol; 2017 Mar; 19(3):345-351. PubMed ID: 28082415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal analysis of a case of multiple meningiomas using multiple molecular genetic approaches: pathology case report.
    Zhu JJ; Maruyama T; Jacoby LB; Herman JG; Gusella JF; Black PM; Wu JK
    Neurosurgery; 1999 Aug; 45(2):409-16. PubMed ID: 10449091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of chromosome 22 and absence of NF2 gene mutation in a case of multiple meningiomas.
    Lomas J; Bello MJ; Alonso ME; Gonzalez-Gomez P; Arjona D; Kusak ME; de Campos JM; Sarasa JL; Rey JA
    Hum Pathol; 2002 Mar; 33(3):375-8. PubMed ID: 11979381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational signature of extracranial meningioma metastases and their respective primary tumors.
    Biczok A; Thorsteinsdottir J; Karschnia P; Ruf VC; Tonn JC; Herms J; Schichor C; Dorostkar MM
    Acta Neuropathol Commun; 2023 Jan; 11(1):12. PubMed ID: 36641486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
    Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
    BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.